Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Mens zelf voornaamste bron van ESBL-besmetting
sep 2019 | Bacteriële infecties